腹水病因临床分析及腹水指标检测对腹水鉴别诊断的价值探讨
[Abstract]:Objective: The clinical symptoms of ascites were different, and their clinical symptoms were different. The etiology of ascites is complicated, and related literature reports indicate that malignant tumor is a common cause of ascites, but also some information indicates that the proportion of liver cirrhosis is high, and the etiology of Bud-Chiari syndrome, malignant mesothelioma, and hepatic vein occlusion is a rare cause of ascites. The method of treatment and prognosis of ascites due to different causes is very important to the etiology of ascites, and how to select an accurate diagnosis method is an urgent problem to be solved by clinical workers. The clinical work is often used to determine the cause of ascites: ascites routine, biochemistry, tumor marker, exfoliative cytology, endoscope, imaging, laparoscope and other means. The diagnosis of malignant ascites has decisive significance for cytology detection of ascites, although its specificity can reach 100%, due to the experience, the number of tumor cell drops, the damage degree of tumor cells, the complex cellular components, the number of cytology tests of ascites exfoliative cytology, The positive rate of non-typical exfoliative cytology was lower. In order to find the index with high sensitivity and specificity, this study provides diagnostic thought and reference information for the diagnosis of ascites due to ascites due to clinical characteristics, ascites biochemistry and tumor marker index. Methods: By retrospective analysis, collected from January 2010 to September 2014 "Ascites to be examined" The clinical data of inpatients with internal medicine were digested in the First Affiliated Hospital of Dalian Medical University, and the sex ratio, age proportion, cause distribution and symptoms of patients were studied. and the value of various indexes in the diagnosis of ascites etiology is comprehensively and accurately evaluated. Results: 155 patients were included in the study. The causes of ascites were cirrhosis ascites (39%), malignant ascites (35%) and tuberculous ascites (14%). The average age of tuberculous ascites was lower, and most of malignant ascites (37%) were digestive tract tumor. The ADA of tuberculous ascites was significantly higher than that of non-tuberculous ascites. The best boundary value for diagnosis of tuberculous ascites was 33. 5U/ L, and the best boundary value suggested tuberculous ascites. The best boundary value of LDH, total protein, AFP, CEA, CA19-9 in malignant ascites was significantly higher than that of benign ascites. The best boundary value of ascites CEA in diagnosis of malignant ascites was 5. 28ug/ L, and the best boundary value of ascites CA19-9 for diagnosis of malignant ascites was 12.75U/ ml. There was no significant difference in ascites fluid in benign and malignant ascites. Conclusion: 1. The first three causes of ascites are cirrhosis ascites, malignant ascites, tuberculous ascites, most malignant ascites is derived from malignant tumor of digestive system. Among the common causes of ascites, the average age of tuberculous ascites was lower than that of patients with cirrhosis and malignant ascites. 4. The symptoms of ascites of liver cirrhosis were seen as diarrhea, and the symptoms of tuberculous ascites were fever and abdominal pain. Ascites ADA has high diagnostic value for tuberculous ascites. Ascites LDH, ascites total protein, ascites AFP, ascites CEA, ascites CA19-9 were valuable for differential diagnosis of benign and malignant ascites. Differential diagnosis of ascites due to ascites has no value in differential diagnosis of benign and malignant ascites.
【学位授予单位】:大连医科大学
【学位级别】:硕士
【学位授予年份】:2015
【分类号】:R442.5
【相似文献】
相关期刊论文 前10条
1 李平,王雅洁,詹忆波;红色诺卡氏菌细胞壁骨架治疗恶性腹水34例临床观察[J];肿瘤学杂志;2001年06期
2 赵心恺,邓志华,郭文栋;血管内皮生长因子对恶性腹水诊断的临床价值[J];中华内科杂志;2004年02期
3 陈岳祥,潘俊;恶性腹水的治疗现状与进展[J];现代医药卫生;2004年09期
4 高峰,程留芳;腹腔-静脉分流术在恶性腹水中的应用[J];胃肠病学和肝病学杂志;2005年03期
5 贾建义;;中西医结合治疗恶性腹水临床研究进展[J];江西中医药;2006年06期
6 金燕;柏愚;李兆申;;恶性腹水的诊治[J];胃肠病学;2008年11期
7 张志红;倪秉强;;恶性腹水的研究进展[J];中国肿瘤临床与康复;2008年04期
8 刘淳;;恶性腹水的诊断与控制研究进展[J];中国现代医生;2012年19期
9 ;良、恶性腹水鉴别诊断的参考意见[J];临床荟萃;1990年04期
10 谢渭芬,张兴荣,张贤康,马述春,陈伟忠,,何晓龙,王成海,路长林;新型重组人肿瘤坏死因子治疗恶性腹水的临床研究[J];免疫学杂志;1995年02期
相关会议论文 前10条
1 邢晓冰;;恶性腹水的诊断及治疗[A];山西省抗癌协会第六届肿瘤学术交流会论文汇编[C];2003年
2 陈岳祥;谢渭芬;;恶性腹水的诊断与治疗现状[A];中华医学会第七次全国消化病学术会议论文汇编(下册)[C];2007年
3 韩松原;;恶性腹水的超声诊断[A];中国超声医学工程学会第七届全国腹部超声学术会议学术论文汇编[C];2007年
4 郭曦;刘天舒;周宇红;王妍;冯艺;李伟;李鸿;;贝伐珠单抗腹腔治疗难治性恶性腹水的近期疗效及安全性分析[A];中国肿瘤内科进展 中国肿瘤医师教育(2014)[C];2014年
5 齐香静;周力;陈晓琴;;腹水多参数检测对鉴别良恶性腹水的诊断价值[A];贵州省中西医结合学会2010年消化系病学术交流会暨非酒精性脂肪肝研究进展学习班资料汇编[C];2010年
6 毋永娟;云文秀;杨燕霞;赵翠云;张巧凤;;腹腔热循环联合顺铂灌注治疗恶性腹水的临床观察[A];中国(第七届)肿瘤微创治疗学术大会暨世界影像导引下肿瘤微创治疗学会成立筹备大会论文汇编[C];2011年
7 王中吉;李纲;江联萍;王梅兴;余华;;腹腔温热灌注药物治疗恶性腹水的临床探讨[A];2000全国肿瘤学术大会论文集[C];2000年
8 陈光群;;中西医结合治疗恶性腹水36例临床观察[A];第九届全国中西医结合肿瘤学术研讨会论文集[C];2002年
9 陈伟训;金珍成;蔡萌芽;姜辉;郑荣浩;陈先配;聂茂伟;赖秀威;;流式细胞术检测DNA诊断恶性腹水的临床价值的研究[A];2007年浙江省消化系疾病学术会议论文汇编[C];2007年
10 徐凯;陈达灿;罗海英;李柳宁;朱迪盈;陈春永;邓宏;张淑香;刘宇龙;;新拟鲤鱼汤治疗恶性腹水的临床观察[A];第九届全国中西医结合肿瘤学术研讨会论文集[C];2002年
相关重要报纸文章 前1条
1 黄金昶;治疗恶性腹水不妨试用药灸脐部[N];家庭医生报;2006年
相关博士学位论文 前3条
1 姚文秀;重组mIL-12基因腺病毒联合顺铂治疗小鼠恶性腹水的实验研究[D];四川大学;2006年
2 刘健;藻酸盐包裹MIP-3α修饰细胞治疗恶性腹水的实验研究[D];四川大学;2004年
3 曹玫;mELC重组腺病毒联合缓释脂质体治疗恶性腹水的研究[D];四川大学;2007年
相关硕士学位论文 前10条
1 张依凡;~(18)F-FDG PET-CT显像在不明原因腹水诊断中的应用价值[D];安徽医科大学;2015年
2 张维维;肿瘤浸润淋巴细胞在卵巢癌中的基础和临床研究[D];南方医科大学;2015年
3 叶晶琳;恶性腹水的中医学术源流及中医治疗研究[D];北京中医药大学;2016年
4 左铁成;腹水病因临床分析及腹水指标检测对腹水鉴别诊断的价值探讨[D];大连医科大学;2015年
5 何贵阳;鉴别良、恶性腹水的数学模型研究[D];中南大学;2009年
6 张惠广;联合检测多项指标对良恶性腹水鉴别的意义[D];山西医科大学;2006年
7 王亚威;SELDI-TOF-MS技术检测腹腔热灌注化疗治疗恶性腹水的机制[D];广州医学院;2010年
8 邓翔宇;腹水、血清中肿瘤标志物及其比值对良恶性腹水的鉴别诊断价值[D];中南大学;2010年
9 陈轶群;肿瘤标志物在良恶性腹水鉴别诊断中的价值探讨[D];福建医科大学;2013年
10 慧妍;良恶性腹水临床预警指标和筛查方案研究[D];内蒙古科技大学包头医学院;2011年
本文编号:2303378
本文链接:https://www.wllwen.com/huliyixuelunwen/2303378.html